Biopharma News

Apr 07, 2014
By BioPharm International Editors
New research finds that recurrent head and neck tumors have gene mutations that could be vulnerable to the cancer drug dasatinib.
Apr 07, 2014
By BioPharm International Editors
European scientists have discovered a method to improve the efficiency of the pharmaceutical production through plant biotechnology.
Apr 07, 2014
By BioPharm International Editors
Sun Pharma acquisition of Ranbaxy Laboratories will create the fifth-largest specialty generics company in the world.
Apr 07, 2014
By BioPharm International Editors
Sun Pharma acquisition of Ranbaxy Laboratories will create the fifth-largest specialty generics company in the world.
Apr 07, 2014
By BioPharm International Editors
Eli Lilly will present early-stage data regarding cancer therapies at AACR 2014.
Mar 27, 2014
By BioPharm International Editors
Baxter announces plans to split into two independent companies by mid-2015.
Mar 24, 2014
By BioPharm International Editors
FDA approves Xolair (omalizumab) for the treatment of a rare skin disease known as chronic idiopathic urticarial.
Mar 24, 2014
By BioPharm International Editors
XstalBio Analytics' approach to vaccine analysis and formulation is aimed at understanding the antigen– adjuvant interaction.
Mar 07, 2014
By BioPharm International Editors
Cobra Biologics and BioCancell announce an agreement to manufacture BioCancell's BC-821 cancer drug.
Mar 04, 2014
By BioPharm International Editors
Novartis calls for more research to understand and find treatments for rare disease.
native1_300x100
lorem ipsum